Dose-dependent effects of oral cannabidiol and delta-9-tetrahydrocannabinol on serum anandamide and related N-acylethanolamines in healthy volunteers

Background The mental health benefits of cannabidiol (CBD) are promising but can be inconsistent, in part due to challenges in defining an individual’s effective dosage. In schizophrenia, alterations in anandamide (AEA) concentrations, an endocannabinoid (eCB) agonist of the eCB system, reflect posi...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Herta Flor, Oliver Grimm, Cathrin Rohleder, Dagmar Koethe, F Markus Leweke, Timothy A Couttas, Carola Boost, Franziska Pahlisch, Eliska B Sykorova, Juliane K Mueller, Beverly Jieu, Judith E Leweke, Inga Dammann, Anna E Hoffmann, Martin Loeffler, Frank Enning, Andreas Meyer-Lindenberg
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMJ Publishing Group 2024-08-01
סדרה:	BMJ Mental Health
גישה מקוונת:	https://ebmh.bmj.com/content/27/1/e301027.full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!